234 related articles for article (PubMed ID: 1830239)
1. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
[TBL] [Abstract][Full Text] [Related]
2. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
Lawrence TS; Davis MA; Maybaum J; Mukhopadhyay SK; Stetson PL; Normolle DP; McKeever PE; Ensminger WD
Cancer Res; 1992 Jul; 52(13):3698-704. PubMed ID: 1617642
[TBL] [Abstract][Full Text] [Related]
3. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ
Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of base excision repair potentiates iododeoxyuridine-induced cytotoxicity and radiosensitization.
Taverna P; Hwang HS; Schupp JE; Radivoyevitch T; Session NN; Reddy G; Zarling DA; Kinsella TJ
Cancer Res; 2003 Feb; 63(4):838-46. PubMed ID: 12591735
[TBL] [Abstract][Full Text] [Related]
5. Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.
Dupertuis YM; Vazquez M; Mach JP; De Tribolet N; Pichard C; Slosman DO; Buchegger F
Cancer Res; 2001 Nov; 61(21):7971-7. PubMed ID: 11691821
[TBL] [Abstract][Full Text] [Related]
6. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
[TBL] [Abstract][Full Text] [Related]
7. Fluorodeoxyuridine modulation of the incorporation of iododeoxyuridine into DNA of granulocytes: a phase I and clinical pharmacological study.
Speth PA; Kinsella TJ; Belanger K; Klecker RW; Smith R; Rowland JB; Collins JM
Cancer Res; 1988 May; 48(10):2933-7. PubMed ID: 2965970
[TBL] [Abstract][Full Text] [Related]
8. The interaction of hydroxyurea and iododeoxyuridine on the radiosensitivity of human bladder cancer cells.
Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
Cancer Res; 1995 Jul; 55(13):2800-5. PubMed ID: 7796406
[TBL] [Abstract][Full Text] [Related]
9. Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells.
Kunugi KA; Vazquez-Padua MA; Miller EM; Kinsella TJ
Cancer Res; 1990 Aug; 50(16):4962-7. PubMed ID: 2199032
[TBL] [Abstract][Full Text] [Related]
10. Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells.
Bruso CE; Shewach DS; Lawrence TS
Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1411-7. PubMed ID: 2148170
[TBL] [Abstract][Full Text] [Related]
11. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation.
Greene RF; Collins JM
Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128
[TBL] [Abstract][Full Text] [Related]
12. The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.
Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
Radiat Res; 1990 Aug; 123(2):192-8. PubMed ID: 2389005
[TBL] [Abstract][Full Text] [Related]
13. Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cells.
Lawrence TS; Davis MA; Maybaum J; Stetson PL; Ensminger WD
Int J Radiat Oncol Biol Phys; 1992; 22(3):499-503. PubMed ID: 1735687
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of 5-fluoro-2'-deoxyuridine antitumor efficacy by the uridine phosphorylase inhibitor 5-(benzyloxybenzyl)barbituric acid acyclonucleoside.
Ashour OM; Naguib FN; Khalifa MM; Abdel-Raheem MH; Panzica RP; el Kouni MH
Cancer Res; 1995 Mar; 55(5):1092-8. PubMed ID: 7866994
[TBL] [Abstract][Full Text] [Related]
15. Low pH does not affect the dose response for 5'-amino-5'-deoxythymidine modulation of IdUrd DNA incorporation and radiosensitization in a human bladder cancer cell line.
Kunugi KA; Miller EM; Vazquez-Padua MA; Kinsella TJ
Radiat Res; 1992 Nov; 132(2):222-7. PubMed ID: 1438704
[TBL] [Abstract][Full Text] [Related]
16. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
17. Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.
McGinn CJ; Kunugi KA; Tutsch KD; Feierabend C; Alberti D; Lindstrom MJ; Wilding G; Arzoomanian RZ; Kinsella TJ
Clin Cancer Res; 1996 Aug; 2(8):1299-305. PubMed ID: 9816300
[TBL] [Abstract][Full Text] [Related]
18. Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas.
Dupertuis YM; Xiao WH; De Tribolet N; Pichard C; Slosman DO; Bischof Delaloye A; Buchegger F
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):499-505. PubMed ID: 11914888
[TBL] [Abstract][Full Text] [Related]
19. Variability of 5-bromo-2'-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidines.
Mancini WR; Stetson PL; Lawrence TS; Wagner JG; Greenberg HS; Ensminger WD
Cancer Res; 1991 Feb; 51(3):870-4. PubMed ID: 1824826
[TBL] [Abstract][Full Text] [Related]
20. ICI D1694 and idoxuridine: a synergistic antitumor combination.
Pressacco J; Hedley DW; Erlichman C
Cancer Res; 1994 Jul; 54(14):3772-8. PubMed ID: 8033097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]